Trial completion date • Trial primary completion date • Combination therapy
|
MYC (V-myc avian myelocytomatosis viral oncogene homolog) • MYCN (MYCN Proto-Oncogene BHLH Transcription Factor)
|
MYCN amplification
|
cyclophosphamide • irinotecan • Danyelza (naxitamab-gqgk)